{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:35:21Z","timestamp":1783809321085,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22207125"],"award-info":[{"award-number":["22207125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107117"],"award-info":[{"award-number":["22107117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473785"],"award-info":[{"award-number":["82473785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bioorg.2025.108158","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:56:00Z","timestamp":1736510160000},"page":"108158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of 1,2,4-benzotriazine derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors"],"prefix":"10.1016","volume":"156","author":[{"given":"Jie","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuquan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-2239","authenticated-orcid":false,"given":"Qi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8103-3603","authenticated-orcid":false,"given":"Kuojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108158_b0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nature Rev Drug Discov"},{"key":"10.1016\/j.bioorg.2025.108158_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bioorg.2025.108158_b0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2472555220952071","article-title":"Development of high-throughput assays for evaluation of hematopoietic progenitor kinase 1 inhibitors","volume":"26","author":"Lacey","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.bioorg.2025.108158_b0020","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1101\/gad.10.18.2251","article-title":"Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK\/SAPK kinase cascade","volume":"10","author":"Hu","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.bioorg.2025.108158_b0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ni1416","article-title":"Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses","volume":"8","author":"Shui","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bioorg.2025.108158_b0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.ai.2015.09.006","article-title":"MAP4K family kinases in immunity and inflammation","volume":"129","author":"Chuang","year":"2016","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bioorg.2025.108158_b0035","doi-asserted-by":"crossref","first-page":"30729","DOI":"10.1074\/jbc.274.43.30729","article-title":"TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton","volume":"274","author":"Fu","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0040","doi-asserted-by":"crossref","first-page":"e55122","DOI":"10.7554\/eLife.55122","article-title":"A perspective on HPK1 as a novel immuno-oncology drug target","volume":"9","author":"Sawasdikosol","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bioorg.2025.108158_b0045","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/MCB.25.6.2364-2383.2005","article-title":"Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1","volume":"25","author":"Arnold","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bioorg.2025.108158_b0050","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1074\/jbc.M101485200","article-title":"Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling","volume":"276","author":"Ling","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.201103105","article-title":"Release of serine\/threonine-phosphorylated adaptors from signaling microclusters down-regulates T cell activation","volume":"195","author":"Lasserre","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bioorg.2025.108158_b0060","doi-asserted-by":"crossref","first-page":"34091","DOI":"10.1074\/jbc.M112.371062","article-title":"Attenuation of T cell receptor signaling by serine phosphorylation-mediated lysine 30 ubiquitination of SLP-76 protein","volume":"287","author":"Wang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0065","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1038\/s41467-024-48014-9","article-title":"HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamics","volume":"15","author":"Chitre","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bioorg.2025.108158_b0070","doi-asserted-by":"crossref","first-page":"11037","DOI":"10.1074\/jbc.M111.310946","article-title":"Down-regulation of B cell receptor signaling by hematopoietic progenitor kinase 1","volume":"287","author":"Wang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0075","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.4049\/jimmunol.0802631","article-title":"Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation","volume":"182","author":"Alzabin","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bioorg.2025.108158_b0080","doi-asserted-by":"crossref","first-page":"e2400920","DOI":"10.1002\/advs.202400920","article-title":"HPK1 dysregulation-associated NK cell dysfunction and defective expansion promotes metastatic melanoma progression","volume":"11","author":"Choi","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.bioorg.2025.108158_b0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00262-009-0761-0","article-title":"Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response","volume":"59","author":"Alzabin","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bioorg.2025.108158_b0090","doi-asserted-by":"crossref","first-page":"34693","DOI":"10.1074\/jbc.M707425200","article-title":"Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway","volume":"282","author":"Sawasdikosol","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0095","doi-asserted-by":"crossref","first-page":"e0243145","DOI":"10.1371\/journal.pone.0243145","article-title":"Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108158_b0100","doi-asserted-by":"crossref","first-page":"551.e11","DOI":"10.1016\/j.ccell.2020.08.001","article-title":"Hematopoietic progenitor kinase1 (HPK1) mediates T cell dysfunction and is a druggable target for T cell-based immunotherapies","volume":"38","author":"Si","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2025.108158_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176184","article-title":"Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models","volume":"961","author":"Setsu","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bioorg.2025.108158_b0110","doi-asserted-by":"crossref","first-page":"e0212670","DOI":"10.1371\/journal.pone.0212670","article-title":"Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance","volume":"14","author":"Liu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108158_b0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.celrep.2018.09.012","article-title":"The kinase activity of hematopoietic progenitor kinase 1 is essential for the regulation of T cell function","volume":"25","author":"Hernandez","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.bioorg.2025.108158_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114819","article-title":"The development of small-molecule inhibitors targeting HPK1","volume":"244","author":"Zhou","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/acsmedchemlett.1c00096","article-title":"Discovery of diaminopyrimidine carboxamide HPK1 inhibitors as preclinical immunotherapy tool compounds","volume":"12","author":"Vara","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bioorg.2025.108158_b0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/acsmedchemlett.0c00660","article-title":"Discovery of orally active isofuranones as potent, selective inhibitors of hematopoetic progenitor kinase 1","volume":"12","author":"Degnan","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bioorg.2025.108158_b0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/acsmedchemlett.1c00473","article-title":"Discovery of spiro-azaindoline inhibitors of hematopoietic progenitor Kinase 1","volume":"13","author":"Chan","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bioorg.2025.108158_b0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/acsmedchemlett.0c00672","article-title":"Identification of potent reverse indazole inhibitors for HPK1","volume":"12","author":"Yu","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bioorg.2025.108158_b0145","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1021\/acs.jmedchem.2c02038","article-title":"Design and synthesis of functionally active 5-amino-6-aryl pyrrolopyrimidine inhibitors of hematopoietic progenitor kinase 1","volume":"66","author":"Gallego","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0150","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1021\/acs.biochem.1c00486","article-title":"Discovery of an allosteric, inactive conformation-selective inhibitor of full-length HPK1 utilizing a kinase cascade assay","volume":"60","author":"Wang","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2025.108158_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116310","article-title":"Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors","volume":"269","author":"Qiu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0160","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c01930","article-title":"Discovery of PF-07265028, A selective small molecule inhibitor of hematopoietic progenitor kinase 1 (HPK1) for the treatment of cancer","author":"Gallego","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0165","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1200\/JCO.2024.42.16_suppl.3083","article-title":"Phase 1\/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab: Clinical update","volume":"42","author":"Noel","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bioorg.2025.108158_b0170","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1200\/JCO.2024.42.16_suppl.2585","article-title":"A first-in-human phase 1a dose-escalation study of BGB-15025 (HPK1 inhibitor) as monotherapy and in combination with tislelizumab (TIS; anti-PD-1 antibody) in patients (pts) with advanced solid tumors","volume":"42","author":"Deva","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bioorg.2025.108158_b0175","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1021\/acsmedchemlett.4c00319","article-title":"Discovery of GNE-6893, a potent, selective, orally bioavailable small molecule inhibitor of HPK1","volume":"15","author":"Tellis","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bioorg.2025.108158_b0180","doi-asserted-by":"crossref","first-page":"17429","DOI":"10.1021\/acs.jmedchem.4c01325","article-title":"Discovery of BAY-405: An azaindole-based MAP4K1 inhibitor for the enhancement of T-cell immunity against cancer","volume":"67","author":"Mowat","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0185","doi-asserted-by":"crossref","first-page":"21520","DOI":"10.1021\/acs.jmedchem.4c02421","article-title":"Discovery of pyridine-2-carboxamides derivatives as potent and selective HPK1 inhibitors for the treatment of cancer","volume":"67","author":"Peng","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106682","article-title":"Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1","volume":"138","author":"Zhou","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115064","article-title":"Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors","volume":"248","author":"Shi","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.fsi.2018.07.040","article-title":"Molecular cloning and bioactivity of an IL-2 homologue in large yellow croaker","volume":"81","author":"Mu","year":"2018","journal-title":"Fish Shellfish Immunol"},{"key":"10.1016\/j.bioorg.2025.108158_b0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/acs.jmedchem.2c01551","article-title":"Discovery of macrocycle-based HPK1 inhibitors for T-cell-based immunotherapy","volume":"66","author":"Wang","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2025.108158_b0210","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.3892\/mmr.2017.7494","article-title":"Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bioorg.2025.108158_b0215","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1073\/pnas.94.18.9687","article-title":"Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase","volume":"94","author":"Diener","year":"1997","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T01:51:01Z","timestamp":1758851461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"alternative-id":["S0045206825000380"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108158","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 1,2,4-benzotriazine derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108158"}}